Xihuang Pill unites gemcitabine on the clinical benefit in advanced pancreatic carcinoma
- VernacularTitle:西黄丸联合吉西他滨对中晚期胰腺癌临床受益的疗效分析
- Author:
Ying ZHANG
;
Yingjie JIA
;
Yiyu SUN
;
Jun CHEN
- Publication Type:Journal Article
- Keywords:
pancreatic carcinoma;
Xihuang Pill;
gemcitabine;
combining treatment with traditional Chinese medicine and western medicine
- From:
Chinese Traditional Patent Medicine
1992;0(01):-
- CountryChina
- Language:Chinese
-
Abstract:
AIM:To evaluate treatment value of Xihuang Pill combined gemcitabine for advanced pancreatic cancer patients.METHODS:Thirty-two patients with advanced pancreatic cancer were randomly divided into A group and B group,treated with gemcitabine chemotherapy and traditional Chinese medicine Xihuang Pill+chemotherapy treatment,respectively.The changes of the solid tumor,serum CA19-9,physical status,clinical symptoms and toxicity were observed.RESULTS:B group(Xihuang Pill combined with gemcitabine)clinical return ratio(CR+PR+NC)was better than A group(gemcitabine).There was significant difference between two groups in the reduction of serum CA19-9 level,Karnofsky score increased,the rate of symptom improvement,Leukopenia reduction(P
